Your browser doesn't support javascript.
B-cell depletion with rituximab in the COVID-19 pandemic: where do we stand?
Mehta, Puja; Porter, Joanna C; Chambers, Rachel C; Isenberg, David A; Reddy, Venkat.
  • Mehta P; Centre for Inflammation and Tissue Repair, UCL Respiratory, Division of Medicine, University College London, London, UK.
  • Porter JC; Department of Rheumatology, University College London Hospital, London NW1 2PG, UK.
  • Chambers RC; Centre for Inflammation and Tissue Repair, UCL Respiratory, Division of Medicine, University College London, London, UK.
  • Isenberg DA; Centre for Inflammation and Tissue Repair, UCL Respiratory, Division of Medicine, University College London, London, UK.
  • Reddy V; Department of Rheumatology, University College London Hospital, London NW1 2PG, UK.
Lancet Rheumatol ; 2(10): e589-e590, 2020 Oct.
Article in English | MEDLINE | ID: covidwho-741637
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Lancet Rheumatol Year: 2020 Document Type: Article Affiliation country: S2665-9913(20)30270-8

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Lancet Rheumatol Year: 2020 Document Type: Article Affiliation country: S2665-9913(20)30270-8